RIGL — Rigel Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Rigel Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	125	58.2	56.9	77.3	155
Net Total Accounts Receivable
Net Total Receivables	15.5	40.3	30.6	41.6	51.8
Total Inventory
Prepaid Expenses
Total Current Assets	154	116	99.3	135	240
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	11.9	2.79	1.03	0.338	0.95
Net Intangible Assets
Other Long Term Assets
Total Assets	167	134	117	164	514
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	63.6	65.2	53.3	63.3	99.2
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	137	148	146	161	122
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	30.4	-13.6	-28.6	3.29	391
Total Liabilities & Shareholders' Equity	167	134	117	164	514
Total Common Shares Outstanding